Kaufman Rossin Wealth LLC Invests $438,000 in UnitedHealth Group Incorporated $UNH

Kaufman Rossin Wealth LLC acquired a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) during the 1st quarter, according to its most recent 13F filing with the SEC. The fund acquired 836 shares of the healthcare conglomerate’s stock, valued at approximately $438,000.

Several other hedge funds also recently added to or reduced their stakes in UNH. Citizens National Bank Trust Department grew its stake in UnitedHealth Group by 1.0% in the first quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate’s stock worth $9,368,000 after purchasing an additional 170 shares in the last quarter. Fort Washington Investment Advisors Inc. OH lifted its holdings in UnitedHealth Group by 0.3% during the 1st quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate’s stock worth $277,641,000 after buying an additional 1,465 shares during the last quarter. Sherbrooke Park Advisers LLC bought a new stake in shares of UnitedHealth Group in the 4th quarter valued at approximately $515,000. Full Sail Capital LLC lifted its stake in UnitedHealth Group by 2.1% during the fourth quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate’s stock worth $815,000 after purchasing an additional 33 shares during the last quarter. Finally, Soros Fund Management LLC bought a new stake in UnitedHealth Group during the fourth quarter valued at $39,413,000. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Trading Down 1.4%

NYSE:UNH opened at $299.8310 on Thursday. The stock has a market cap of $271.55 billion, a price-to-earnings ratio of 12.99, a PEG ratio of 1.96 and a beta of 0.43. The business has a fifty day moving average of $288.81 and a 200-day moving average of $392.90. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $630.73. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The company had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business’s quarterly revenue was up 12.9% on a year-over-year basis. During the same quarter in the prior year, the company earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be given a dividend of $2.21 per share. The ex-dividend date is Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.9%. UnitedHealth Group’s dividend payout ratio (DPR) is 38.30%.

Insider Activity at UnitedHealth Group

In other news, CEO Patrick Hugh Conway sold 589 shares of the company’s stock in a transaction on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the completion of the sale, the chief executive officer owned 10,398 shares in the company, valued at $3,171,390. This represents a 5.36% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Corporate insiders own 0.28% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on UNH. Wells Fargo & Company decreased their price target on shares of UnitedHealth Group from $306.00 to $267.00 and set an “overweight” rating for the company in a report on Monday, August 4th. Raymond James Financial lowered UnitedHealth Group from a “strong-buy” rating to a “market perform” rating in a report on Wednesday, May 14th. Erste Group Bank downgraded UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Wednesday, April 30th. HSBC reaffirmed a “reduce” rating and issued a $270.00 target price (down from $490.00) on shares of UnitedHealth Group in a research report on Wednesday, May 21st. Finally, Piper Sandler lowered their price target on shares of UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating for the company in a research report on Wednesday, July 30th. Fifteen equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $365.38.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.